YCBD Valuation

cbdMD Inc

Add to Watchlist

Advanced Chart

0.950

+0.02(2.151%)1D

Overview
Forecast
Valuation
Earnings

YCBD Relative Valuation

YCBD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, YCBD is overvalued; if below, it's undervalued.

Historical Valuation

cbdMD Inc (YCBD) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.38 is considered Undervalued compared with the five-year average of -8.61. The fair price of cbdMD Inc (YCBD) is between 17.19 to 17.63 according to relative valuation methord. Compared to the current price of 0.95 USD , cbdMD Inc is Undervalued By 94.47%.

Relative Value

Fair Zone

17.19-17.63

Current Price：0.95

94.47%

Undervalued

-0.38

Trailing

Forward

0.00

EV/EBITDA

cbdMD Inc. (YCBD) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is -56.15. The thresholds are as follows: Strongly Undervalued below -418.32, Undervalued between -418.32 and -237.23, Fairly Valued between 124.93 and -237.23, Overvalued between 124.93 and 306.02, and Strongly Overvalued above 306.02. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.

-7.70

EV/EBIT

cbdMD Inc. (YCBD) has a current EV/EBIT of -7.70. The 5-year average EV/EBIT is -28.34. The thresholds are as follows: Strongly Undervalued below -258.04, Undervalued between -258.04 and -143.19, Fairly Valued between 86.51 and -143.19, Overvalued between 86.51 and 201.36, and Strongly Overvalued above 201.36. The current Forward EV/EBIT of -7.70 falls within the Historic Trend Line -Fairly Valued range.

0.38

cbdMD Inc. (YCBD) has a current PS of 0.38. The 5-year average PS is 1.14. The thresholds are as follows: Strongly Undervalued below -1.42, Undervalued between -1.42 and -0.14, Fairly Valued between 2.42 and -0.14, Overvalued between 2.42 and 3.69, and Strongly Overvalued above 3.69. The current Forward PS of 0.38 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

cbdMD Inc. (YCBD) has a current P/OCF of 0.00. The 5-year average P/OCF is -14.03. The thresholds are as follows: Strongly Undervalued below -65.20, Undervalued between -65.20 and -39.61, Fairly Valued between 11.55 and -39.61, Overvalued between 11.55 and 37.13, and Strongly Overvalued above 37.13. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

cbdMD Inc. (YCBD) has a current P/FCF of 0.00. The 5-year average P/FCF is -7.67. The thresholds are as follows: Strongly Undervalued below -39.42, Undervalued between -39.42 and -23.54, Fairly Valued between 8.21 and -23.54, Overvalued between 8.21 and 24.09, and Strongly Overvalued above 24.09. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

cbdMD Inc (YCBD) has a current Price-to-Book (P/B) ratio of 1.13. Compared to its 3-year average P/B ratio of 0.59 , the current P/B ratio is approximately 90.96% higher. Relative to its 5-year average P/B ratio of 0.92, the current P/B ratio is about 22.77% higher. cbdMD Inc (YCBD) has a Forward Free Cash Flow (FCF) yield of approximately -2.90%. Compared to its 3-year average FCF yield of -91.89%, the current FCF yield is approximately -96.85% lower. Relative to its 5-year average FCF yield of -62.56% , the current FCF yield is about -95.37% lower.

1.13

P/B

Median3y

0.59

Median5y

0.92

-2.90

FCF Yield

Median3y

-91.89

Median5y

-62.56

Competitors Valuation Multiple

The average P/S ratio for YCBD's competitors is 30.08, providing a benchmark for relative valuation. cbdMD Inc Corp (YCBD) exhibits a P/S ratio of 0.38, which is -98.72% above the industry average. Given its robust revenue growth of 8.52%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

PharmaCyte Biotech Inc

Qualigen Therapeutics Inc

Loss

4.58M

ENVB.O

Enveric Biosciences Inc

Performance Decomposition

Market capitalization of YCBD decreased by 79.53% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 4.38M to 4.75M.

The secondary factor is the P/E Change, contributed -2.76%to the performance.

Overall, the performance of YCBD in the past 1 year is driven by Revenue Growth. Which is more sustainable.

8.52%

4.38M → 4.75M

Revenue Growth

-85.29%

-68.79 → -10.12

Margin Expansion

-2.76%

-0.16 → -0.16

P/E Change

-79.53%